Goran Marijanovic

Dr. Goran Marijanovic


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Open access
GMGoran Marijanovic
Goran Marijanovic
ASAleksandra Stojanovic
Aleksandra Stojanovic
MNMarina R. Nikolic
Marina R. Nikolic
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
TVTatjana Vulovic
Tatjana Vulovic
This study aimed to examine the effect of thiopental monotherapy as well as its combination with different agents used in anesthesia induction, on cardiac function and redox state of rats with type 1 diabetes mellitus (T1DM). A total of 40 Wistar albino male rats were used in this study and randomly divided into five groups: thiopental (TIO), fentanyl + thiopental (FEN + TIO), remifentanil + thiopental (REM + TIO), midazolam + thiopental (MID + TIO), and dexmedetomidine + thiopental (DEX + TIO). Animals were anesthetized by intraperitoneal injection of thiopental 85 mg/kg, fentanyl 0.005 mg/kg, remifentanil 0.04 mg/kg, midazolam 2.5 mg/kg, and dexmedetomidine 0.05 mg/kg of body weight. Four weeks after T1DM induction, all animals were subjected to a short narcosis of tested anesthetic, sacrificed by cervical dislocation and the hearts were retrogradely perfused according to Langendorff technique. Our research demonstrated that most combined anesthetics negatively influenced cardiodynamic parameters and redox state in diabetic rats. However, significantly improved cardiac contractility associated with enhanced antioxidative capacity was achieved in the combination of TIO with REM, which distinguishes this anesthetic combination as the therapy with the most pronounced positive effect on cardiac function in state of T1DM.

1 December 2014 in Praxis medica
Verified
Journal Article
Open access
PDF file
GMGoran Marijanovic
Goran Marijanovic
ZTZ. Terzic
Z. Terzic
MCM. Cmiljanic
M. Cmiljanic
MPM. Paunovic
M. Paunovic
NVN. Vucetic
N. Vucetic
LRLj. Radunovic
Lj. Radunovic
Dezmoidne ili agresivne fibromatoze pripadaju grupi benignih tumora koje karakteriše lokalno infiltrativan rast i sklonost recidiviranju, a koje ne metastaziraju. Prikazana je žena starosti 46 godina, koja dolazi na pregled zbog recidivantnog tumora prednjeg trbušnog zida, ranije PH verifikovanog kao dezmoidna fibromatoza. Uz tumor prednjeg trbušnog zida dimenzija 14.7x7.0x12.5 cm, CT dijagnostikom otkriven je i tumor veličine 5.8x6.2x8.8 cm u loži ranije odstranjenog desnog bubrega, koji je u bliskoj komunikaciji sa donjom šupljom venom (VCI) i desnom zajedničkom ilijačnom aretrijom (AIC dex.). Kompresija na iste je rezultirala otokom desne noge u cjelosti, koji se povukao nakon ekscizije tumora. Postoperativni tok je protekao uredno.

1 June 2021 in Serbian Journal of Experimental and Clinical Research
Verified
Journal Article
Open access
PDF file
GMGoran Marijanovic
Goran Marijanovic
LRLjubica Radunovic
Ljubica Radunovic
Postoperative nausea and vomiting (PONV) is a patient-important outcome; patients often rate PONV as worse than postoperative pain. This clinical study was aimed to asses the efficiency of standard aniemetics administration separately or in combination in prevention of PONV in patients who underwent to the same surgical procedure - laparoscopic cholecystectomy. Also, this article could provide a novel information about the best choice for prevention and treatment of PONV. This study included 87 patients divided into four groups according to the postoperative phramacological treatment: First group was control group without treatment, Second group was group of patients with ondasetron treatment in postoperative period, Third group was group of patients with ondasetron+dexamethasone treatment, and fourth group was group of patients with dexamethasone treatment in postoperative period for nausea. PONV was distributed in Ondansetron+Dexamethasone group in the lowest percent (4.5%), which means that this conbination of antiemetics was very effective. Than, Dexamethasone group was in relation with low incidence of PONV (14.3%), and after that were Ondansetron and Control groups. Also smokers and males has lower incidence of PONV, especially in combination with Ondansetron+Dexamethasone treatment. The incidence of PONV is lower in male smokers patients who were underwent to combination of two antiemetics, ondansetron and dexamethasone compared to monotherapy and female non-smokers. Preventive strategies for PONV must include risk stratification followed by prophylactic approach and also testing the newer antiemetics. Because of the high incidence of postoperative nausea and vomiting as a patient-important outcome, the preventive strategies should be considered as serious condition which requires multimodal approach.